National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 77476-77477 [2013-30402]
Download as PDF
<![CDATA[
77476
Federal Register / Vol. 78, No. 246 / Monday, December 23, 2013 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
Research Coordinating Committee
(IPRCC) meeting.
The meeting will feature invited
speakers and discussions of committee
business items including the National
Pain Strategy, a searchable data base for
the Federally-funded pain research
portfolio, and opportunities for
partnerships in pain research.
The meeting will be open to the
public and accessible by live webcast
and conference call.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Type of meeting: Open Meeting.
Date: February 4, 2014.
Time: 8:30 a.m. to 5:00 p.m. *Eastern
Time*—Approximate end time.
Agenda: The meeting will feature invited
speakers and discussions of Committee
business items including the National Pain
Strategy, a searchable data base for the
Federally-funded pain research portfolio, and
opportunities for partnerships in pain
research.
Place: National Institutes of Health,
Building 31, C Wing, Conference Room 6, 31
Center Drive, Bethesda, MD 20892.
Conference Call: Dial: 888–790–2053.
Participant Passcode: 1866472.
Cost: The meeting is free and open to the
public.
Webcast Live: https://videocast.nih.gov/.
Registration: https://iprcc.nih.gov/.
Deadlines: Notification of intent to present
oral comments: Friday, January 24, 2014, by
5:00 p.m. E.T.
Submission of written/electronic statement
for oral comments: Tuesday, January 28,
2014, by 5:00 p.m. E.T.
Submission of written comments:
Thursday, January 30, 2014, by 5:00 p.m. E.T.
Access: Medical Center Metro (Red Line).
Visitor Information: https://www.nih.gov/
about/visitor/index.htm.
Contact Person: Linda L. Porter, Ph.D.,
Pain Policy Advisor, Office of Pain Policy,
Officer of the Director, National Institute of
Neurological Disorders and Stroke, NIH, 31
Center Drive, Room 8A03, Bethesda, MD
20892, Phone: (301) 496–9271, Email: IPRCC
PublicInquiries@mail.nih.gov.
Please Note. Any member of the public
interested in presenting oral comments to the
Committee must notify the Contact Person
listed on this notice by 5:00 p.m. ET on
Friday, January 24, 2014, with their request
to present oral comments at the meeting.
Interested individuals and representatives of
organizations must submit a written/
electronic copy of the oral statement/
comments including a brief description of the
organization represented by 5:00 p.m. ET on
Tuesday, January 28, 2014.
Statements submitted will become a part of
the public record. Only one representative of
an organization will be allowed to present
oral comments on behalf of that organization,
and presentations will be limited to three to
five minutes per speaker, depending on
number of speakers to be accommodated
within the allotted time. Speakers will be
assigned a time to speak in the order of the
date and time when their request to speak is
VerDate Mar<15>2010
18:12 Dec 20, 2013
Jkt 232001
received, along with the required submission
of the written/electronic statement by the
specified deadline. If special
accommodations are needed, please email
the Contact Person listed above.
In addition, any interested person may
submit written comments to the IPRCC prior
to the meeting by sending the comments to
the Contact Person listed on this notice by
5:00 p.m. ET, Thursday, January 30, 2014.
The comments should include the name and,
when applicable, the business or professional
affiliation of the interested person. All
written comments received by the deadlines
for both oral and written public comments
will be provided to the IPRCC for their
consideration and will become part of the
public record.
The meeting will be open to the public
through a conference call phone number and
webcast live on the Internet. Members of the
public who participate using the conference
call phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with the
conference call or webcast, please call
Operator Service on (301) 496–4517 for
conference call issues and the NIH IT Service
Desk at (301) 496–4357, toll free (866) 319–
4357, for webcast issues.
Individuals who participate in person or by
using these electronic services and who need
special assistance, such as captioning of the
conference call or other reasonable
accommodations, should submit a request to
the Contact Person listed on this notice at
least seven days prior to the meeting.
As a part of security procedures, attendees
should be prepared to present a photo ID
during the security process to get on the NIH
campus. For a full description, please see:
https://www.nih.gov/about/
visitorsecurity.htm.
Information about the IPRCC is available
on the Web site: https://iprcc.nih.gov/.
Dated: December 17, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–30399 Filed 12–20–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; TBI Legacy Data for FITBIR.
Date: January 6, 2014.
Time: 3:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: William C. Benzing, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–496–0660, benzingw@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
December 17, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–30407 Filed 12–20–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Renal Supportive
Care Studies.
Date: January 8, 2014.
Time: 4:00 p.m. to 5:00 p.m.
E:\FR\FM\23DEN1.SGM
23DEN1
Federal Register / Vol. 78, No. 246 / Monday, December 23, 2013 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Carol J. Goter-Robinson,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 748, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7791,
goterrobinsonc@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS).
Dated: December 17, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–30402 Filed 12–20–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)
(4) and 552b(c) (6), Title 5 U.S.C., as
amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Small Business Development of New
Methods for Mitral Valve Repair.
Date: January 10, 2014.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7196, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Stephanie J. Webb, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7196, Bethesda, MD 20892, 301–435–0291,
stephanie.webb@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
VerDate Mar<15>2010
18:12 Dec 20, 2013
Jkt 232001
77477
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS).
DEPARTMENT OF HOMELAND
SECURITY
Dated: December 17, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
Notice of Statute of Limitations on
Claims; Notice of Final Federal Agency
Action on the Interstate 5 Bridge
across the Columbia River
[FR Doc. 2013–30395 Filed 12–20–13; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: January 10, 2014.
Time: 11:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Camilla E. Day, Ph.D.,
Scientific Review Officer, CIDR, National
Human Genome Research Institute, National
Institutes of Health, 5635 Fishers Lane, Suite
4075, Bethesda, MD 20892, 301–402–8837,
camilla.day@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS).
Dated: December 17, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–30405 Filed 12–20–13; 8:45 am]
BILLING CODE 4140–01–P
Frm 00061
Fmt 4703
[Docket No. USCG–2013–1038]
Coast Guard, DHS.
Notice of limitation on claims
for judicial review.
AGENCY:
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Coast Guard
Sfmt 4703
This notice announces the
Coast Guard’s final action on the
issuance of a Coast Guard bridge permit,
adoption of the bridge related portions
of the Federal Highway Administration
(FHWA)/Federal Transit Administration
(FTA) prepared Final Environmental
Impact Statement (FEIS) and issuance of
a Record of Decision (ROD) for the
Interstate 5 bridge across the Columbia
River between Vancouver, Washington
and Portland, Oregon.
DATES: A claim seeking judicial review
of the Coast Guard’s action on the
Columbia River Crossing project will be
barred unless the claim is filed on or
before May 22, 2014.
FOR FURTHER INFORMATION CONTACT:
Brian Dunn, Chief, Office of Bridge
Programs, Commandant (CG–BRG),
Attn: Office of Bridge Programs, U.S.
Coast Guard Stop 7418, 2703 Martin
Luther King Jr Ave, SE., Washington, DC
20593–7418, available 8 a.m.–4 p.m.,
EST, Monday through Friday, except
Federal holidays, phone number (202)
372–1511 or email: brian.dunn@
uscg.mil.
SUMMARY:
This
notice is issued under the authority of
the Freedom of Information Act, 5
U.S.C. 552(a).
Notice is hereby given that the Coast
Guard, under its General Bridge Act of
1946 permit authority, 33 U.S.C. 525–
533, has taken final agency action(s)
subject to 23 U.S.C. 139(I)(1) by issuing
a bridge permit. In addition, and in
accordance with the National
Environmental Policy Act (NEPA), the
Coast Guard also adopted the bridge
related portions of the FHWA/FTA
prepared FEIS and issued a ROD. The
project involves replacing the I–5 bridge
across navigable waters of the United
States by replacing the existing lift
bridge with a fixed bridge. As a
structure over navigable waters of the
United States, the proposed bridge
requires a Coast Guard bridge permit.
The Coast Guard issued a bridge permit
on September 27, 2013 for the proposed
new fixed bridge. FHWA and FTA were
SUPPLEMENTARY INFORMATION:
E:\FR\FM\23DEN1.SGM
23DEN1
]]>Agencies
[Federal Register Volume 78, Number 246 (Monday, December 23, 2013)]
[Notices]
[Pages 77476-77477]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-30402]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Renal Supportive Care
Studies.
Date: January 8, 2014.
Time: 4:00 p.m. to 5:00 p.m.
[[Page 77477]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Carol J. Goter-Robinson, Ph.D., Scientific
Review Officer, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 748, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-7791, goterrobinsonc@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS).
Dated: December 17, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-30402 Filed 12-20-13; 8:45 am]
BILLING CODE 4140-01-P
